Tag:

Infectious Diseases

Latest Headlines

Latest Headlines

U.S. bioterror readiness highlighted after NIH smallpox discovery

The discovery of vials of "variola," commonly known as smallpox, in a storage room at the National Institutes of Health in Bethesda, MD, has raised new concerns that the virus could be used in a bioterrorism attack.

Ongoing Ebola outbreak sparks debate on experimental vaccine testing

International debate is brewing over whether to give experimental vaccines to people in regions of the current Ebola outbreak in West Africa in an effort to thwart the spread of the deadly virus.

UPDATED: Agenus' genital herpes vax cuts viral load 75% in PhII

After hitting its primary endpoint in a Phase II study last fall, Agenus was already leading a Sanofi-NIH collaboration in efforts to develop the first genital herpes vaccine. Now, it's built on that lead with new Phase II results for its therapeutic candidate, HerpV, which achieved statistical significance in reducing viral load.

Themis Chikungunya prophylactic hits Phase I goal

Chikungunya fever is a dangerous tropical virus that has recently surfaced in the U.S. after erupting in the Caribbean. But Austria-based Themis Bioscience may eventually have a way to combat it, new data suggest. 

Scripps, U. of Nebraska-Lincoln win $15M to advance HIV vaccines

The Scripps Research Institute has landed a $13 million grant from the National Institute of Allergy and Infectious Diseases to advance antibodies toward the development of an HIV vaccine. Meanwhile, another team of researchers at the University of Nebraska-Lincoln has won nearly $2 million for its experimental HIV vaccine.

Study: Cholera vaccine has 86% effectiveness rate

Two doses of the oral cholera vaccine Shanchol provided an 86% percent protection rate during a recent outbreak in Guinea, according to a new study.

Pandemic flu vaccine research poses risk of unintended release

Virulent flu strains pose the danger of potential release, even when used in experiments for vaccine research, and investigators from the Harvard and Yale universities are calling for greater scrutiny of such studies.

CIA abandons use of vaccine programs for spying

Polio is on the rise in Pakistan, in part because of fears that Western vaccine workers there could be doubling as spies. But according to the CIA, that should no longer be a concern.

Sanofi C. diff vaccine shows immune response in PhII trial

BOSTON-- Sanofi's Phase II trial results for its Clostridium difficile vaccine are proof that the French drug giant is leading the race for preventive therapies for the deadly bacterial infection.

MERS an 'emerging market opportunity,' Novavax CFO says

Last month, critics questioned whether developing a vaccine for Middle East respiratory syndrome made any real sense for governments or vaccinemakers. But fast-forward a few weeks and everyone seems to be paying a little more attention.